Table 5.
The prevalence of Toxoplasma gondii IgG antibodies in Arabs (non-Bedouins) and Bedouins by sociodemographic parameters
| Variable | Arabs (non-Bedouins) | Bedouins | ||||
|---|---|---|---|---|---|---|
| Prevalence (%) | OR (95% CI) | P | Prevalence (%) | OR (95% CI) | P | |
| Age group (yr) | ||||||
| <10 | 10·9 | Ref. | 3·2 | Ref. | ||
| 10–19 | 33·3 | 4·1 (2·1–7·8) | <0·001 | 15·3 | 5·5 (1·1–26·6) | 0·03 |
| 20–29 | 72·6 | 21·6 (9·8–47·4) | <0·001 | 20·5 | 7·8 (4·6–38·4) | 0·01 |
| 30–39 | 78·0 | 28·8 (12·6–66·0) | <0·001 | 24·4 | 9·8 (2·2–43·9) | 0·003 |
| 40–49 | 83·8 | 42·2 (18·0–98·9) | <0·001 | 38·7 | 19·2 (4·4–84·7) | <0·001 |
| 50–59 | 91·9 | 92·3 (33·9–251·5) | <0·001 | 48·7 | 29·0 (6·2–135·4) | <0·001 |
| ⩾60 | 96·0 | 195·4 (42·8–893·1) | <0·001 | 59·1 | 44·1 (8·5–228·3) | <0·001 |
| Gender | ||||||
| Male | 51·4 | Ref. | 25·0 | Ref. | ||
| Female | 58·3 | 1·3 (1·0–1·8) | 0·09 | 27·2 | 1·1 (0·7–1·8) | 0·64 |
| Area of residence | ||||||
| Rural | 52·8 | Ref. | 21·8 | Ref. | ||
| Urban | 56·8 | 1·2 (0·8–1·6) | 0·35 | 30·6 | 1·6 (1·0–2·5) | 0·05 |
| Socioeconomic status | ||||||
| High | 44·2 | Ref. | − | − | ||
| Low | 56·3 | 1·6 (0·9–2·9) | 0·09 | − | − | |
OR, Odds ratio; CI, confidence interval.